MOMTAZEE JAMES C 4
4 · Roivant Sciences Ltd. · Filed Jan 22, 2026
Research Summary
AI-generated summary of this filing
Roivant (ROIV) Director James C. Momtazee Receives Award
What Happened
James C. Momtazee, a director of Roivant Sciences (ROIV), was awarded 609 common shares on 2026-01-20 under the company's Non-Employee Director Compensation Plan; the award was fully vested as of the grant date. To satisfy tax withholding on the vested shares, 122 shares were net-settled (disposed) to the issuer at an implied price of $22.98 per share, resulting in $2,804 withheld.
Key Details
- Transaction dates: 2026-01-20 (award and net settlement for taxes). Form filed 2026-01-22.
- Award: 609 shares granted, $0.00 acquisition price (vesting-based award).
- Tax withholding: 122 shares disposed at $22.98 each, totaling $2,804 (net settlement by issuer).
- Shares owned after transaction: not specified in the provided filing details.
- Footnotes: F1 = award was fully vested at grant. F2 = the 122-share disposal reflects the issuer's net settlement to satisfy tax withholding.
- Timeliness: Filing covers a 2026-01-20 transaction and was submitted 2026-01-22 (appears timely).
Context: This was a vested director award (not an option exercise or open-market trade). The 122-share disposal was a routine, issuer-handled net settlement to cover withholding taxes and is standard for equity compensation — it should not be interpreted as an independent sell signal about company prospects.
Insider Transaction Report
- Award
Common Shares
[F1]2026-01-20+609→ 109,152 total - Tax Payment
Common Shares
[F2]2026-01-20$22.98/sh−122$2,804→ 109,030 total
Footnotes (2)
- [F1]Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
- [F2]Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.